Dr. Eoin Flanagan talks with Dr. Tomas Kalincik about his paper, "Associations of Disease-Modifying Therapies With COVID-19 Severity in Multiple Sclerosis".
Show references: https://n.neurology.org/content/early/2021/10/05/WNL.0000000000012753
Want to check another podcast?
Enter the RSS feed of a podcast, and see all of their public statistics.